Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Attenuation of AMPA receptor-mediated neurotoxicity by YM-90K

Feb. 16, 1998

Egis patents compounds affecting the central and peripheral serotonergic system

Feb. 16, 1998

CCKB/gastrin receptor antagonists with anxiolytic activity discovered at Rotta

Feb. 16, 1998

M2 ligands reported for the treatment of dementia

Feb. 16, 1998

SA-4503 may improve spatial learning performance in rats

Feb. 16, 1998

Parkinson's patch yields positive results

Feb. 16, 1998

Efficacy of eliprodil and combination therapy in a rat embolic stroke model

Feb. 16, 1998

GTS-21 protects against amnesia, neuronal death in gerbil model of cerebral ischemia

Feb. 13, 1998

SS Pharm. licenses AChE inhibitor to Arena

Feb. 13, 1998

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...